Catheter-based tricuspid valve replacement: first experimental data of a newly designed bileaflet stent graft prosthesis

• Published in: European journal of cardio-thoracic surgery Vol. 52; no. 1; pp. 189 - 196
• Main Authors: Lausberg, Henning F., Gryszkiewicz, Rafal, Kuetting, Maximilian, Baumgaertner, Moritz, Centola, Marcos, Wendel, Hans-Peter, Nowak-Machen, Martina, Schibilsky, David, Kruger, Tobias, Schlensak, Christian
• Format: Journal Article
• Language: English
• Published: Germany Oxford University Press 01.07.2017
• Subjects: Tricuspid valve disease; Transcatheter valve therapy; Tricuspid valve replacement; Experimental
• ISSN: 1010-7940; 1873-734X
• DOI: 10.1093/ejcts/ezx084

Abstract OBJECTIVES: Moderate or severe degree tricuspid valve regurgitation (TVR) is associated with high rates of morbidity and mortality. Surgical correction as the only therapeutic option offers unsatisfactory results. Recently, several interventional procedures have been introduced clinically in a limited cohort. We present our initial experiments with an innovative interventional valved stent graft for treatment of TVR. METHODS: A newly designed porcine pericardium-covered nitinol stent graft with a lateral bicuspid valve was adapted to size in a cadaver study. After haemodynamic testing in an ex vivo perfusion setup, vascular access, valve delivery and function were investigated in an ovine animal model (n = 7). RESULTS: The device was implanted successfully in all animals. Vascular access was established surgically via the femoral vein without any vascular complications. Angiography demonstrated the correct position of the device with proper sealing of both venae cavae in 6 animals. In 1 extremely large animal, the position of the device was considered too cranial but still acceptable. Correct valve function was verified in all animals by both angiography and echocardiography. There were no persistent arrhythmias other than during valve implant. All animals survived the implant procedure and were sacrificed electively. CONCLUSIONS: This study demonstrated that this new valved stent graft could be delivered safely with correct positioning and valve function in this ovine model. Further long-term studies in animals implanted with the device after creation of tricuspid regurgitation are necessary to prove the haemodynamic benefit of this procedure.